$3.030
-0.049 (-1.62%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ENTX Prediction & Forecast by Similar Chart Analysis
Alphio's ENTX stock price prediction model matches the current Entera Bio Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.05 (+0.65%). The 1-week path is $3.10 (+2.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Entera Bio Ltd Stock?
Entera Bio Ltd (ENTX) is currently trading at $3.03, which is significantly below the analyst target of $9, indicating potential upside. However, the company reported a net loss of $7.31 million in Q2 2026, which is a considerable increase from previous losses, raising concerns about its financial health. The RSI is at 42.035, suggesting the stock is approaching oversold territory but not yet at a strong buy signal. Given the recent oversubscribed financing of $275 million, which is expected to support its Phase 3 program for EB613, there are positive catalysts. However, the risk of increasing net losses and the current price being below the SMA_200 of $1.745 indicates caution. Therefore, while there is potential for growth, the financial instability and recent losses suggest holding rather than buying at this time.
ENTX stock price ended at $3.03 on Friday, after losing -1.62%
Entera Bio Ltd (ENTX) last closed at $3.03, losing -1.62%. These facts feed the 1-day and 1-week ENTX price prediction above.
Analyst Consensus
Entera Bio Ltd (ENTX): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Entera Bio Ltd (ENTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ENTX, ranked by similarity.
Seasonality analysis for ENTX
Historically the probability of a positive August return for ENTX is 66.67%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ENTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.88 | $2.33 | $2.75 | -23.23% |
| Sep 2026 | $1.43 | $1.83 | $2.01 | -39.62% |
| Oct 2026 | $2.21 | $2.48 | $2.66 | -18.30% |
| Nov 2026 | $1.92 | $1.99 | $2.28 | -34.26% |
| Dec 2026 | $2.07 | $2.27 | $2.31 | -25.21% |
In 2026, Entera Bio Ltd (ENTX) is projected to range from $1.43 to $2.75.
Entera Bio Ltd 2026 monthly forecast
In Aug 2026, Entera Bio Ltd is projected to average $2.33, with a low of $1.88 and high of $2.75.
In Sep 2026, Entera Bio Ltd is projected to average $1.83, with a low of $1.43 and high of $2.01.
In Oct 2026, Entera Bio Ltd is projected to average $2.48, with a low of $2.21 and high of $2.66.
In Nov 2026, Entera Bio Ltd is projected to average $1.99, with a low of $1.92 and high of $2.28.
In Dec 2026, Entera Bio Ltd is projected to average $2.27, with a low of $2.07 and high of $2.31.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.